PuSH - Publication Server of Helmholtz Zentrum München

Gross, C.* ; Holler, E.* ; Stangl, S. ; Dickinson, A.* ; Pockley, A.G. ; Asea, A.A.* ; Mallappa, N.* ; Multhoff, G.

An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.

Leuk. Res. 32, 527-537 (2008)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
In contrast to solid tumors, leukemic blasts frequently present both Hsp70 and HLA-E on their cell surface and thereby present activating and inhibitory signals to CD94(+) NK cells. In the first 12 months after stem cell transplantation (SCT) CD94(+) NK cells clearly dominate over CD3(+)/CD16(-)/56(-) T and CD3(+)/CD16(+)/56(+) NK-like T cells. An incubation of post-SCT-derived peripheral blood lymphocytes with the Hsp70 peptide TKD and IL-15 enhances the cell surface density of CD56/CD94 and initiates the cytolytic activity of NK cells against Hsp70/HLA-E double-positive autologous and allogeneic leukemic blasts. Hsp70 was identified as the target structure for TKD-activated NK cells.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.561
0.710
9
10
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Hsp70 peptide TKD; HLA-E; NK cells; Stem cell transplantation; Cytotoxicity
Language english
Publication Year 2008
HGF-reported in Year 0
ISSN (print) / ISBN 0145-2126
e-ISSN 1873-5835
Quellenangaben Volume: 32, Issue: 4, Pages: 527-537 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
Institute(s) CCG Innate Immunity in Tumor Biology (PATH-KTB)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
PSP Element(s) G-521400-001
PubMed ID 17543383
Erfassungsdatum 2008-03-14